Akero Therapeutics Inc (AKRO) Insider Trading
- $44,791,272.50
- $138,805,956.83
- Dec. 16, 2024
- Andrew Cheng
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 8, 2023 | Director | 100,000 | $19.83 | Buy | $1,983,000.00 | |
Nov. 30, 2023 | Director | 50,000 | $16.90 | Buy | $845,000.00 | |
Nov. 17, 2023 | COO | 30,000 | $14.68 | Sell | $440,400.00 | |
Oct. 2, 2023 | CEO | 25,000 | $47.91 | Sell | $1,197,750.00 | |
Oct. 2, 2023 | COO | 490 | $51.10 | Sell | $25,039.00 | |
Sept. 21, 2023 | Insider | 5,000 | $48.07 | Sell | $240,350.00 | |
Aug. 28, 2023 | Insider | 5,745 | $49.99 | Sell | $287,192.55 | |
Aug. 8, 2023 | Director | 25,000 | $42.06 | Buy | $1,051,500.00 | |
Aug. 1, 2023 | Director | 25,000 | $43.26 | Buy | $1,081,500.00 | |
July 28, 2023 | Director | 30,000 | $42.69 | Buy | $1,280,700.00 | |
July 3, 2023 | CEO | 25,000 | $44.88 | Sell | $1,122,000.00 | |
June 23, 2023 | Insider | 11,000 | $50.76 | Sell | $558,360.00 | |
June 21, 2023 | Insider | 11,349 | $52.26 | Sell | $593,098.74 | |
June 20, 2023 | CFO | 20,777 | $55.00 | Sell | $1,142,735.00 | |
June 16, 2023 | Insider | 78,200 | $54.78 | Sell | $4,283,796.00 | |
June 16, 2023 | Director | 26,000 | $54.67 | Sell | $1,421,420.00 | |
June 13, 2023 | COO | 538 | $55.16 | Sell | $29,676.08 | |
June 13, 2023 | CFO | 606 | $55.16 | Sell | $33,426.96 | |
June 13, 2023 | Insider | 509 | $55.16 | Sell | $28,076.44 | |
June 13, 2023 | CEO | 1,613 | $55.16 | Sell | $88,973.08 | |
June 1, 2023 | CEO | 25,000 | $45.10 | Sell | $1,127,500.00 | |
May 19, 2023 | Director | 120,000 | $42.00 | Buy | $5,040,000.00 | |
May 1, 2023 | CEO | 25,000 | $45.07 | Sell | $1,126,750.00 | |
April 3, 2023 | CEO | 25,000 | $37.94 | Sell | $948,500.00 | |
March 1, 2023 | CEO | 25,000 | $46.65 | Sell | $1,166,250.00 | |
Feb. 1, 2023 | CEO | 25,000 | $49.06 | Sell | $1,226,500.00 | |
Jan. 13, 2023 | Insider | 5,000 | $50.53 | Sell | $252,650.00 | |
Jan. 3, 2023 | CEO | 25,000 | $51.27 | Sell | $1,281,750.00 | |
Jan. 3, 2023 | COO | 8,777 | $54.64 | Sell | $479,575.28 | |
Dec. 28, 2022 | Insider | 1,700 | $50.00 | Sell | $85,000.00 | |
Dec. 28, 2022 | CFO | 999 | $49.76 | Sell | $49,710.24 | |
Dec. 27, 2022 | COO | 12,500 | $49.57 | Sell | $619,625.00 | |
Dec. 12, 2022 | Insider | 5,000 | $43.23 | Sell | $216,150.00 | |
Dec. 1, 2022 | CEO | 10,000 | $46.07 | Sell | $460,700.00 | |
Dec. 1, 2022 | Major Shareholder | 1,636,000 | $43.50 | Sell | $71,166,000.00 | |
Nov. 30, 2022 | Director | 11,101 | $46.94 | Sell | $521,080.94 | |
Nov. 15, 2022 | Insider | 3,138 | $45.04 | Sell | $141,335.52 | |
Nov. 10, 2022 | Insider | 5,000 | $39.42 | Sell | $197,100.00 | |
Nov. 1, 2022 | CEO | 10,000 | $43.42 | Sell | $434,200.00 | |
Oct. 27, 2022 | Director | 66,426 | $41.53 | Sell | $2,758,671.78 | |
Oct. 25, 2022 | COO | 12,500 | $44.72 | Sell | $559,000.00 | |
Oct. 25, 2022 | Director | 4,515 | $44.92 | Sell | $202,813.80 | |
Oct. 25, 2022 | Insider | 10,653 | $45.09 | Sell | $480,343.77 | |
Oct. 13, 2022 | CFO | 20,000 | $39.82 | Sell | $796,400.00 | |
Oct. 10, 2022 | Insider | 5,000 | $37.99 | Sell | $189,950.00 | |
Oct. 6, 2022 | Insider | 22,500 | $39.29 | Sell | $884,025.00 | |
Oct. 3, 2022 | CEO | 10,000 | $33.23 | Sell | $332,300.00 | |
Sept. 30, 2022 | Insider | 45,000 | $32.72 | Sell | $1,472,400.00 | |
Sept. 13, 2022 | Insider | 40,000 | $27.48 | Sell | $1,099,200.00 | |
Sept. 13, 2022 | CEO | 60,000 | $27.42 | Sell | $1,645,200.00 |
Insiders are both buying and selling Akero Therapeutics Inc stock.
The insider traders at Akero Therapeutics Inc are: Andrew Cheng, Catriona Yale, Jonathan Young, William Richard White, Timothy Rolph, G. Walmsley Graham, Seth Loring Harrison, Patrick Lamy, Global Strategic Fund I Venbio, Kevin Bitterman, Skorpios Trust, Aaron Royston, Tomas J. Heyman, and Apple Tree Partners Iv, L.P.
The most active insider trader at Akero Therapeutics Inc is Andrew Cheng with 29 trades.
Skorpios Trust has sold the most Akero Therapeutics Inc stock with a total value of $142,332,000.00.
Apple Tree Partners Iv, L.P. has bought the most Akero Therapeutics Inc stock with a total value of $29,880,000.00.
The most recent insider trade for Akero Therapeutics Inc was on Dec. 16, 2024.
The single biggest insider buy for Akero Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $14,940,000.00 on July 10, 2020.
The single biggest insider sell for Akero Therapeutics Inc was from Skorpios Trust with a total value of $71,166,000.00 on Dec. 1, 2022.